Skip to main content
SupplementScience

L-Carnitine — Frequently Asked Questions

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Frequently Asked Questions

Does L-carnitine help burn fat?

In most people, no. L-carnitine is required for fatty acid transport into mitochondria, but healthy omnivores already have saturated muscle carnitine stores. Supplementation does not increase muscle carnitine levels meaningfully unless taken with substantial carbohydrates (80+ g) to spike insulin. Potential exceptions include strict vegetarians/vegans (who may have lower carnitine status) and elderly individuals.

Which form of carnitine should I take?

It depends on your goal. For exercise recovery: L-carnitine L-tartrate (LCLT) at 2-3 g/day. For brain health: acetyl-L-carnitine (ALCAR) at 1.5-3 g/day. For general use: base L-carnitine is cheapest. For cardiovascular/blood flow: propionyl-L-carnitine (GPLC). Do not assume forms are interchangeable — they have different tissue distributions and evidence bases.

Should I worry about TMAO from carnitine?

TMAO (trimethylamine N-oxide) is produced when gut bacteria metabolize carnitine, and elevated TMAO has been associated with cardiovascular risk in observational studies. However, the clinical significance for supplement users is debated. Regular exercisers and fish-eaters (who also produce TMAO) do not show increased CV risk. Moderate doses (1-3 g/day) are likely fine for healthy individuals, but those with existing cardiovascular disease may want to consult a physician.

References

  1. (). Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate. Journal of Strength and Conditioning Research. DOI
  2. (). Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. Journal of Physiology. DOI
  3. (). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology. DOI